<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-01" modified="2017-05-10" version="191">
<accession>O15111</accession>
<accession>O14666</accession>
<accession>Q13132</accession>
<accession>Q5W0I4</accession>
<accession>Q92467</accession>
<name>IKKA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Inhibitor of nuclear factor kappa-B kinase subunit alpha</fullName>
<shortName>I-kappa-B kinase alpha</shortName>
<shortName>IKK-A</shortName>
<shortName>IKK-alpha</shortName>
<shortName>IkBKA</shortName>
<shortName>IkappaB kinase</shortName>
<ecNumber>2.7.11.10</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Conserved helix-loop-helix ubiquitous kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>I-kappa-B kinase 1</fullName>
<shortName>IKK1</shortName>
</alternativeName>
<alternativeName>
<fullName>Nuclear factor NF-kappa-B inhibitor kinase alpha</fullName>
<shortName>NFKBIKA</shortName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor 16</fullName>
<shortName>TCF-16</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">CHUK</name>
<name type="synonym">IKKA</name>
<name type="synonym">TCF16</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Cell" volume="90" first="373" last="383">
<title>Identification and characterization of an IkappaB kinase.</title>
<authorList>
<person name="Regnier C.H."/>
<person name="Song H.Y."/>
<person name="Gao X."/>
<person name="Goeddel D.V."/>
<person name="Cao Z."/>
<person name="Rothe M."/>
</authorList>
<dbReference type="PubMed" id="9244310"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80344-X"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>MUTAGENESIS OF LYS-44</scope>
<scope>VARIANT ILE-268</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Nature" volume="388" first="548" last="554">
<title>A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.</title>
<authorList>
<person name="DiDonato J.A."/>
<person name="Hayakawa M."/>
<person name="Rothwarf D.M."/>
<person name="Zandi E."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="9252186"/>
<dbReference type="DOI" id="10.1038/41493"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>VARIANT ILE-268</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="278" first="860" last="866">
<title>IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.</title>
<authorList>
<person name="Mercurio F."/>
<person name="Zhu H."/>
<person name="Murray B.W."/>
<person name="Shevchenko A."/>
<person name="Bennett B.L."/>
<person name="Li J.W."/>
<person name="Young D.B."/>
<person name="Barbosa M."/>
<person name="Mann M."/>
<person name="Manning A."/>
<person name="Rao A."/>
</authorList>
<dbReference type="PubMed" id="9346484"/>
<dbReference type="DOI" id="10.1126/science.278.5339.860"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>MUTAGENESIS OF LYS-44 AND SER-176</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="Gene" volume="222" first="31" last="40">
<title>IkappaB kinase-alpha and -beta genes are coexpressed in adult and embryonic tissues but localized to different human chromosomes.</title>
<authorList>
<person name="Hu M.C.-T."/>
<person name="Wang Y.-P."/>
</authorList>
<dbReference type="PubMed" id="9813230"/>
<dbReference type="DOI" id="10.1016/S0378-1119(98)00462-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ILE-268</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT ILE-268</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="Cell. Mol. Biol. Res." volume="41" first="537" last="549">
<title>CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain.</title>
<authorList>
<person name="Connelly M.A."/>
<person name="Marcu K.B."/>
</authorList>
<dbReference type="PubMed" id="8777433"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 32-745</scope>
<scope>VARIANT ILE-268</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="18574" last="18579">
<title>Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.</title>
<authorList>
<person name="Mittal R."/>
<person name="Peak-Chew S.Y."/>
<person name="McMahon H.T."/>
</authorList>
<dbReference type="PubMed" id="17116858"/>
<dbReference type="DOI" id="10.1073/pnas.0608995103"/>
</citation>
<scope>PROTEIN SEQUENCE OF 169-181</scope>
<scope>INACTIVATION BY YERSINIA YOPJ (MICROBIAL INFECTION)</scope>
<scope>ACETYLATION AT THR-179 (MICROBIAL INFECTION)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Nature" volume="395" first="292" last="296">
<title>IKAP is a scaffold protein of the IkappaB kinase complex.</title>
<authorList>
<person name="Cohen L."/>
<person name="Henzel W.J."/>
<person name="Baeuerle P.A."/>
</authorList>
<dbReference type="PubMed" id="9751059"/>
<dbReference type="DOI" id="10.1038/26254"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH IKBKB; NFKBIA; RELA; IKBKAP AND MAP3K14</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="3792" last="3797">
<title>NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176.</title>
<authorList>
<person name="Ling L."/>
<person name="Cao Z."/>
<person name="Goeddel D.V."/>
</authorList>
<dbReference type="PubMed" id="9520446"/>
<dbReference type="DOI" id="10.1073/pnas.95.7.3792"/>
</citation>
<scope>PHOSPHORYLATION AT SER-176</scope>
<scope>MUTAGENESIS OF SER-176; THR-179 AND SER-180</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Nature" volume="401" first="82" last="85">
<title>NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.</title>
<authorList>
<person name="Ozes O.N."/>
<person name="Mayo L.D."/>
<person name="Gustin J.A."/>
<person name="Pfeffer S.R."/>
<person name="Pfeffer L.M."/>
<person name="Donner D.B."/>
</authorList>
<dbReference type="PubMed" id="10485710"/>
<dbReference type="DOI" id="10.1038/43466"/>
</citation>
<scope>PHOSPHORYLATION AT THR-23</scope>
<scope>MUTAGENESIS OF THR-23</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Science" volume="284" first="309" last="313">
<title>Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.</title>
<authorList>
<person name="Delhase M."/>
<person name="Hayakawa M."/>
<person name="Chen Y."/>
<person name="Karin M."/>
</authorList>
<dbReference type="PubMed" id="10195894"/>
<dbReference type="DOI" id="10.1126/science.284.5412.309"/>
</citation>
<scope>INTERACTION WITH IKBKB</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="7336" last="7343">
<title>Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase.</title>
<authorList>
<person name="Nemoto S."/>
<person name="DiDonato J.A."/>
<person name="Lin A."/>
</authorList>
<dbReference type="PubMed" id="9819420"/>
<dbReference type="DOI" id="10.1128/MCB.18.12.7336"/>
</citation>
<scope>IKK PHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Am. J. Physiol." volume="278" first="C451" last="C462">
<title>The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection.</title>
<authorList>
<person name="Jobin C."/>
<person name="Sartor R.B."/>
</authorList>
<dbReference type="PubMed" id="10712233"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3549" last="3561">
<title>Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.</title>
<authorList>
<person name="Wu R.-C."/>
<person name="Qin J."/>
<person name="Hashimoto Y."/>
<person name="Wong J."/>
<person name="Xu J."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="11971985"/>
<dbReference type="DOI" id="10.1128/MCB.22.10.3549-3561.2002"/>
</citation>
<scope>SUBUNIT OF A COMPLEX CONTAINING CREBBP; NCOA2; NCOA3; IKBKB AND IKBKG</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="2029" last="2041">
<title>Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation.</title>
<authorList>
<person name="Tegethoff S."/>
<person name="Behlke J."/>
<person name="Scheidereit C."/>
</authorList>
<dbReference type="PubMed" id="12612076"/>
<dbReference type="DOI" id="10.1128/MCB.23.6.2029-2041.2003"/>
</citation>
<scope>COMPOSITION OF THE IKK COMPLEX</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Nature" volume="423" first="655" last="659">
<title>Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.</title>
<authorList>
<person name="Yamamoto Y."/>
<person name="Verma U.N."/>
<person name="Prajapati S."/>
<person name="Kwak Y.T."/>
<person name="Gaynor R.B."/>
</authorList>
<dbReference type="PubMed" id="12789342"/>
<dbReference type="DOI" id="10.1038/nature01576"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF HISTONE H3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Cell" volume="117" first="225" last="237">
<title>IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.</title>
<authorList>
<person name="Hu M.C."/>
<person name="Lee D.F."/>
<person name="Xia W."/>
<person name="Golfman L.S."/>
<person name="Ou-Yang F."/>
<person name="Yang J.Y."/>
<person name="Zou Y."/>
<person name="Bao S."/>
<person name="Hanada N."/>
<person name="Saso H."/>
<person name="Kobayashi R."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="15084260"/>
<dbReference type="DOI" id="10.1016/S0092-8674(04)00302-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXO3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51897" last="51907">
<title>PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages.</title>
<authorList>
<person name="Bruey J.-M."/>
<person name="Bruey-Sedano N."/>
<person name="Newman R."/>
<person name="Chandler S."/>
<person name="Stehlik C."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="15456791"/>
<dbReference type="DOI" id="10.1074/jbc.M406741200"/>
</citation>
<scope>INTERACTION WITH NALP2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="8603" last="8607">
<title>beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.</title>
<authorList>
<person name="Witherow D.S."/>
<person name="Garrison T.R."/>
<person name="Miller W.E."/>
<person name="Lefkowitz R.J."/>
</authorList>
<dbReference type="PubMed" id="15173580"/>
<dbReference type="DOI" id="10.1073/pnas.0402851101"/>
</citation>
<scope>INTERACTION WITH ARRB1 AND ARRB2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Nature" volume="437" first="1167" last="1172">
<title>Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.</title>
<authorList>
<person name="Meylan E."/>
<person name="Curran J."/>
<person name="Hofmann K."/>
<person name="Moradpour D."/>
<person name="Binder M."/>
<person name="Bartenschlager R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="16177806"/>
<dbReference type="DOI" id="10.1038/nature04193"/>
</citation>
<scope>INTERACTION WITH MAVS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Cell" volume="129" first="903" last="914">
<title>Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.</title>
<authorList>
<person name="Liu B."/>
<person name="Yang Y."/>
<person name="Chernishof V."/>
<person name="Loo R.R."/>
<person name="Jang H."/>
<person name="Tahk S."/>
<person name="Yang R."/>
<person name="Mink S."/>
<person name="Shultz D."/>
<person name="Bellone C.J."/>
<person name="Loo J.A."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="17540171"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.03.056"/>
</citation>
<scope>INTERACTION WITH PIAS1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Mol. Cell" volume="26" first="75" last="87">
<title>Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.</title>
<authorList>
<person name="Huang W.C."/>
<person name="Ju T.K."/>
<person name="Hung M.C."/>
<person name="Chen C.C."/>
</authorList>
<dbReference type="PubMed" id="17434128"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.02.019"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CREBBP</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Immunol. Res." volume="42" first="3" last="18">
<title>The IkappaB kinase complex: master regulator of NF-kappaB signaling.</title>
<authorList>
<person name="Solt L.A."/>
<person name="May M.J."/>
</authorList>
<dbReference type="PubMed" id="18626576"/>
<dbReference type="DOI" id="10.1007/s12026-008-8025-1"/>
</citation>
<scope>REVIEW</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="4073" last="4089">
<title>SGK1 phosphorylation of IkappaB Kinase alpha and p300 Up-regulates NF-kappaB activity and increases N-Methyl-D-aspartate receptor NR2A and NR2B expression.</title>
<authorList>
<person name="Tai D.J."/>
<person name="Su C.C."/>
<person name="Ma Y.L."/>
<person name="Lee E.H."/>
</authorList>
<dbReference type="PubMed" id="19088076"/>
<dbReference type="DOI" id="10.1074/jbc.M805055200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-23 AND SER-180 BY SGK1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cell" volume="33" first="30" last="42">
<title>PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination.</title>
<authorList>
<person name="Li S."/>
<person name="Wang L."/>
<person name="Dorf M.E."/>
</authorList>
<dbReference type="PubMed" id="19150425"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.11.023"/>
</citation>
<scope>INTERACTION WITH TRAF2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Cell" volume="141" first="483" last="496">
<title>NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.</title>
<authorList>
<person name="Cui J."/>
<person name="Zhu L."/>
<person name="Xia X."/>
<person name="Wang H.Y."/>
<person name="Legras X."/>
<person name="Hong J."/>
<person name="Ji J."/>
<person name="Shen P."/>
<person name="Zheng S."/>
<person name="Chen Z.J."/>
<person name="Wang R.F."/>
</authorList>
<dbReference type="PubMed" id="20434986"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.03.040"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NLRC5</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="N. Engl. J. Med." volume="363" first="1631" last="1637">
<title>Mutant CHUK and severe fetal encasement malformation.</title>
<authorList>
<person name="Lahtela J."/>
<person name="Nousiainen H.O."/>
<person name="Stefanovic V."/>
<person name="Tallila J."/>
<person name="Viskari H."/>
<person name="Karikoski R."/>
<person name="Gentile M."/>
<person name="Saloranta C."/>
<person name="Varilo T."/>
<person name="Salonen R."/>
<person name="Kestila M."/>
</authorList>
<dbReference type="PubMed" id="20961246"/>
<dbReference type="DOI" id="10.1056/NEJMoa0911698"/>
</citation>
<scope>INVOLVEMENT IN COCOS</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA41" last="RA41">
<title>Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.</title>
<authorList>
<person name="Razani B."/>
<person name="Zarnegar B."/>
<person name="Ytterberg A.J."/>
<person name="Shiba T."/>
<person name="Dempsey P.W."/>
<person name="Ware C.F."/>
<person name="Loo J.A."/>
<person name="Cheng G."/>
</authorList>
<dbReference type="PubMed" id="20501937"/>
<dbReference type="DOI" id="10.1126/scisignal.2000778"/>
</citation>
<scope>FUNCTION IN MAP3K14 PHOSPHORYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Nat. Immunol." volume="12" first="834" last="843">
<title>The kinase IKKalpha inhibits activation of the transcription factor NF-kappaB by phosphorylating the regulatory molecule TAX1BP1.</title>
<authorList>
<person name="Shembade N."/>
<person name="Pujari R."/>
<person name="Harhaj N.S."/>
<person name="Abbott D.W."/>
<person name="Harhaj E.W."/>
</authorList>
<dbReference type="PubMed" id="21765415"/>
<dbReference type="DOI" id="10.1038/ni.2066"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TAX1BP1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="42856" last="42866">
<title>The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-kappaB signaling.</title>
<authorList>
<person name="Wang W."/>
<person name="Guo M."/>
<person name="Hu L."/>
<person name="Cai J."/>
<person name="Zeng Y."/>
<person name="Luo J."/>
<person name="Shu Z."/>
<person name="Li W."/>
<person name="Huang Z."/>
</authorList>
<dbReference type="PubMed" id="23091055"/>
<dbReference type="DOI" id="10.1074/jbc.M112.399923"/>
</citation>
<scope>INTERACTION WITH ZNF268</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2015" name="Cell. Signal." volume="27" first="2343" last="2354">
<title>IFIT5 positively regulates NF-kappaB signaling through synergizing the recruitment of IkappaB kinase (IKK) to TGF-beta-activated kinase 1 (TAK1).</title>
<authorList>
<person name="Zheng C."/>
<person name="Zheng Z."/>
<person name="Zhang Z."/>
<person name="Meng J."/>
<person name="Liu Y."/>
<person name="Ke X."/>
<person name="Hu Q."/>
<person name="Wang H."/>
</authorList>
<dbReference type="PubMed" id="26334375"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2015.08.018"/>
</citation>
<scope>INTERACTION WITH IFIT5</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] CYS-126; ALA-155 AND ILE-268</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Structure" volume="16" first="798" last="808">
<title>Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.</title>
<authorList>
<person name="Rushe M."/>
<person name="Silvian L."/>
<person name="Bixler S."/>
<person name="Chen L.L."/>
<person name="Cheung A."/>
<person name="Bowes S."/>
<person name="Cuervo H."/>
<person name="Berkowitz S."/>
<person name="Zheng T."/>
<person name="Guckian K."/>
<person name="Pellegrini M."/>
<person name="Lugovskoy A."/>
</authorList>
<dbReference type="PubMed" id="18462684"/>
<dbReference type="DOI" id="10.1016/j.str.2008.02.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 732-745</scope>
</reference>
<comment type="function">
<text evidence="9 10 17 22 23 25">Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B on serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Negatively regulates the pathway by phosphorylating the scaffold protein TAXBP1 and thus promoting the assembly of the A20/TNFAIP3 ubiquitin-editing complex (composed of A20/TNFAIP3, TAX1BP1, and the E3 ligases ITCH and RNF11). Therefore, CHUK plays a key role in the negative feedback of NF-kappa-B canonical signaling to limit inflammatory gene activation. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. In turn, these complexes regulate genes encoding molecules involved in B-cell survival and lymphoid organogenesis. Participates also in the negative feedback of the non-canonical NF-kappa-B signaling pathway by phosphorylating and destabilizing MAP3K14/NIK. Within the nucleus, phosphorylates CREBBP and consequently increases both its transcriptional and histone acetyltransferase activities. Modulates chromatin accessibility at NF-kappa-B-responsive promoters by phosphorylating histones H3 at 'Ser-10' that are subsequently acetylated at 'Lys-14' by CREBBP. Additionally, phosphorylates the CREBBP-interacting protein NCOA3. Also phosphorylates FOXO3 and may regulate this pro-apoptotic transcription factor (PubMed:15084260).</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [I-kappa-B protein] = ADP + [I-kappa-B phosphoprotein].</text>
</comment>
<comment type="enzyme regulation">
<text>Activated when phosphorylated and inactivated when dephosphorylated.</text>
</comment>
<comment type="subunit">
<text evidence="2 5 7 8 10 12 13 14 18 21 22 26 27 33">Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex (PubMed:10195894, PubMed:12612076). The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65 (By similarity). Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP (PubMed:11971985). Part of a 70-90 kDa complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA, IKBKAP and MAP3K14 (PubMed:9751059). Directly interacts with TRPC4AP (By similarity). May interact with TRAF2 (PubMed:19150425). Interacts with NALP2 (PubMed:15456791). May interact with MAVS/IPS1 (PubMed:16177806). Interacts with ARRB1 and ARRB2 (PubMed:15173580). Interacts with NLRC5; prevents CHUK phosphorylation and kinase activity (PubMed:20434986). Interacts with PIAS1; this interaction induces PIAS1 phosphorylation (PubMed:17540171). Interacts with ZNF268 isoform 2; the interaction is further increased in a TNF-alpha-dependent manner (PubMed:23091055). Interacts with FOXO3 (PubMed:15084260). Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation (PubMed:26334375).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-714559">
<id>P32121</id>
<label>ARRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-519280">
<id>P46527</id>
<label>CDKN1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-866453">
<id>P03129</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-9690349">
<id>Q07857</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-9690312">
<id>Q6TY28</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-9690239">
<id>Q6TY35</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-9690278">
<id>Q80901</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-9690330">
<id>Q8B5B5</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-306914">
<id>Q13451</id>
<label>FKBP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-968267">
<id>Q92985</id>
<label>IRF7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-358011">
<id>Q99558</id>
<label>MAP3K14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-1057380">
<id>Q5TCX8</id>
<label>MLK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-307386">
<id>P25963</id>
<label>NFKBIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-6149376">
<id>Q77M19</id>
<label>P</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-529518">
<id>Q86VP1</id>
<label>TAX1BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81249"/>
<interactant intactId="EBI-4291651">
<id>P24772</id>
<label>VACWR196</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Nucleus</location>
</subcellularLocation>
<text>Shuttles between the cytoplasm and the nucleus.</text>
</comment>
<comment type="tissue specificity">
<text>Widely expressed.</text>
</comment>
<comment type="domain">
<text evidence="19">The kinase domain is located in the N-terminal region. The leucine zipper is important to allow homo- and hetero-dimerization. At the C-terminal region is located the region responsible for the interaction with NEMO/IKBKG.</text>
</comment>
<comment type="PTM">
<text>Phosphorylated by MAP3K14/NIK, AKT and to a lesser extent by MEKK1, and dephosphorylated by PP2A. Autophosphorylated.</text>
</comment>
<comment type="PTM">
<text evidence="15">(Microbial infection) Acetylation of Thr-179 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the I-kappa-B signaling pathway.</text>
</comment>
<comment type="disease" evidence="24">
<disease id="DI-02978">
<name>Cocoon syndrome</name>
<acronym>COCOS</acronym>
<description>A lethal syndrome characterized by multiple fetal malformations including defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin.</description>
<dbReference type="MIM" id="613630"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="3">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/chuk/"/>
</comment>
<dbReference type="EC" id="2.7.11.10"/>
<dbReference type="EMBL" id="AF012890">
<property type="protein sequence ID" value="AAC51662.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF009225">
<property type="protein sequence ID" value="AAC51671.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF080157">
<property type="protein sequence ID" value="AAD08996.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY652653">
<property type="protein sequence ID" value="AAT49098.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL138921">
<property type="protein sequence ID" value="CAH72401.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U22512">
<property type="protein sequence ID" value="AAC50713.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7488.1"/>
<dbReference type="RefSeq" id="NP_001269.3">
<property type="nucleotide sequence ID" value="NM_001278.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.198998"/>
<dbReference type="PDB" id="3BRT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/C=732-745"/>
</dbReference>
<dbReference type="PDB" id="5EBZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=10-660"/>
</dbReference>
<dbReference type="PDB" id="5TQW">
<property type="method" value="EM"/>
<property type="resolution" value="5.60"/>
<property type="chains" value="A/B=10-660"/>
</dbReference>
<dbReference type="PDB" id="5TQX">
<property type="method" value="EM"/>
<property type="resolution" value="5.40"/>
<property type="chains" value="A/B=10-660"/>
</dbReference>
<dbReference type="PDB" id="5TQY">
<property type="method" value="EM"/>
<property type="resolution" value="5.20"/>
<property type="chains" value="A/B=10-660"/>
</dbReference>
<dbReference type="PDBsum" id="3BRT"/>
<dbReference type="PDBsum" id="5EBZ"/>
<dbReference type="PDBsum" id="5TQW"/>
<dbReference type="PDBsum" id="5TQX"/>
<dbReference type="PDBsum" id="5TQY"/>
<dbReference type="ProteinModelPortal" id="O15111"/>
<dbReference type="SMR" id="O15111"/>
<dbReference type="BioGrid" id="107569">
<property type="interactions" value="130"/>
</dbReference>
<dbReference type="DIP" id="DIP-27526N"/>
<dbReference type="IntAct" id="O15111">
<property type="interactions" value="59"/>
</dbReference>
<dbReference type="MINT" id="MINT-88648"/>
<dbReference type="STRING" id="9606.ENSP00000359424"/>
<dbReference type="BindingDB" id="O15111"/>
<dbReference type="ChEMBL" id="CHEMBL3476"/>
<dbReference type="DrugBank" id="DB06151">
<property type="generic name" value="Acetylcysteine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00233">
<property type="generic name" value="Aminosalicylic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00244">
<property type="generic name" value="Mesalazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00795">
<property type="generic name" value="Sulfasalazine"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1989"/>
<dbReference type="iPTMnet" id="O15111"/>
<dbReference type="PhosphoSitePlus" id="O15111"/>
<dbReference type="BioMuta" id="CHUK"/>
<dbReference type="EPD" id="O15111"/>
<dbReference type="MaxQB" id="O15111"/>
<dbReference type="PaxDb" id="O15111"/>
<dbReference type="PeptideAtlas" id="O15111"/>
<dbReference type="PRIDE" id="O15111"/>
<dbReference type="Ensembl" id="ENST00000370397">
<property type="protein sequence ID" value="ENSP00000359424"/>
<property type="gene ID" value="ENSG00000213341"/>
</dbReference>
<dbReference type="GeneID" id="1147"/>
<dbReference type="KEGG" id="hsa:1147"/>
<dbReference type="UCSC" id="uc001kqp.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1147"/>
<dbReference type="DisGeNET" id="1147"/>
<dbReference type="GeneCards" id="CHUK"/>
<dbReference type="H-InvDB" id="HIX0201495"/>
<dbReference type="HGNC" id="HGNC:1974">
<property type="gene designation" value="CHUK"/>
</dbReference>
<dbReference type="HPA" id="CAB004240"/>
<dbReference type="HPA" id="CAB018564"/>
<dbReference type="HPA" id="HPA001402"/>
<dbReference type="MalaCards" id="CHUK"/>
<dbReference type="MIM" id="600664">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613630">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O15111"/>
<dbReference type="OpenTargets" id="ENSG00000213341"/>
<dbReference type="PharmGKB" id="PA26510"/>
<dbReference type="eggNOG" id="KOG4250">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRMU">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00820000127009"/>
<dbReference type="HOGENOM" id="HOG000038048"/>
<dbReference type="HOVERGEN" id="HBG018241"/>
<dbReference type="InParanoid" id="O15111"/>
<dbReference type="KO" id="K04467"/>
<dbReference type="OMA" id="FVLMDHI"/>
<dbReference type="OrthoDB" id="EOG091G02VC"/>
<dbReference type="PhylomeDB" id="O15111"/>
<dbReference type="TreeFam" id="TF324269"/>
<dbReference type="BRENDA" id="2.7.11.10">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236974">
<property type="pathway name" value="ER-Phagosome pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198323">
<property type="pathway name" value="AKT phosphorylates targets in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446652">
<property type="pathway name" value="Interleukin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357905">
<property type="pathway name" value="Regulation of TNFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357956">
<property type="pathway name" value="TNFR1-induced NFkappaB signaling pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5602636">
<property type="pathway name" value="IKBKB deficiency causes SCID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603027">
<property type="pathway name" value="IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5603029">
<property type="pathway name" value="IkBA variant leads to EDA-ID"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607761">
<property type="pathway name" value="Dectin-1 mediated noncanonical NF-kB signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674400">
<property type="pathway name" value="Constitutive Signaling by AKT1 E17K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5676590">
<property type="pathway name" value="NIK-->noncanonical NF-kB signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5684264">
<property type="pathway name" value="MAP3K8 (TPL2)-dependent MAPK1/3 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937039">
<property type="pathway name" value="IRAK1 recruits IKK complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975144">
<property type="pathway name" value="IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="SABIO-RK" id="O15111"/>
<dbReference type="SignaLink" id="O15111"/>
<dbReference type="SIGNOR" id="O15111"/>
<dbReference type="ChiTaRS" id="CHUK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O15111"/>
<dbReference type="GeneWiki" id="CHUK"/>
<dbReference type="GenomeRNAi" id="1147"/>
<dbReference type="PRO" id="PR:O15111"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000213341"/>
<dbReference type="CleanEx" id="HS_CHUK"/>
<dbReference type="Genevisible" id="O15111">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0035631">
<property type="term" value="C:CD40 receptor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0008385">
<property type="term" value="C:IkappaB kinase complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008384">
<property type="term" value="F:IkappaB kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097110">
<property type="term" value="F:scaffold protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009653">
<property type="term" value="P:anatomical structure morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002479">
<property type="term" value="P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071276">
<property type="term" value="P:cellular response to cadmium ion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098586">
<property type="term" value="P:cellular response to virus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038061">
<property type="term" value="P:NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1902741">
<property type="term" value="P:positive regulation of interferon-alpha secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010803">
<property type="term" value="P:regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010034">
<property type="term" value="P:response to acetate"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043200">
<property type="term" value="P:response to amino acid"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033194">
<property type="term" value="P:response to hydroperoxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009636">
<property type="term" value="P:response to toxic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007266">
<property type="term" value="P:Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003009">
<property type="term" value="P:skeletal muscle contraction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051146">
<property type="term" value="P:striated muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="InterPro" id="IPR022007">
<property type="entry name" value="IKKbetaNEMObind"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF12179">
<property type="entry name" value="IKKbetaNEMObind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01239">
<property type="entry name" value="IKKbetaNEMObind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Inhibitor of nuclear factor kappa-B kinase subunit alpha" id="PRO_0000086011">
<location>
<begin position="1"/>
<end position="745"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="3">
<location>
<begin position="15"/>
<end position="302"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="3">
<location>
<begin position="21"/>
<end position="29"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="455"/>
<end position="476"/>
</location>
</feature>
<feature type="region of interest" description="NEMO-binding">
<location>
<begin position="738"/>
<end position="743"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="3 4">
<location>
<position position="144"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="3">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKB/AKT1 and SGK1" evidence="6 20">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K14" evidence="32">
<location>
<position position="176"/>
</location>
</feature>
<feature type="modified residue" description="O-acetylthreonine; by Yersinia yopJ" evidence="15">
<location>
<position position="179"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by SGK1" evidence="20">
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34427437." id="VAR_040565" evidence="16">
<original>S</original>
<variation>C</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230803." id="VAR_040566" evidence="16">
<original>V</original>
<variation>A</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230804." id="VAR_021359" evidence="11 16 28 29 30 34">
<original>V</original>
<variation>I</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation and decrease of kinase activity." evidence="6">
<original>T</original>
<variation>A</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="29 31">
<original>K</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation." evidence="29 31">
<original>K</original>
<variation>M</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation and of activity." evidence="31 32">
<original>S</original>
<variation>A</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Full activation." evidence="31 32">
<original>S</original>
<variation>E</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in phosphorylation." evidence="32">
<original>T</original>
<variation>A</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in phosphorylation." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC51671." ref="2" evidence="35">
<original>E</original>
<variation>G</variation>
<location>
<position position="543"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAC50713." ref="7" evidence="35">
<original>L</original>
<variation>R</variation>
<location>
<position position="604"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAC50713." ref="7" evidence="35">
<original>TS</original>
<variation>AY</variation>
<location>
<begin position="679"/>
<end position="680"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; no nucleotide entry and 7; AAC50713." ref="3 7" evidence="35">
<original>P</original>
<variation>A</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAC50713." ref="7" evidence="35">
<original>TS</original>
<variation>DL</variation>
<location>
<begin position="686"/>
<end position="687"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="735"/>
<end position="737"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="741"/>
<end position="743"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BRT"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q60680"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10195894"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10485710"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971985"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612076"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12789342"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15084260"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15164054"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15173580"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456791"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16177806"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17116858"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17434128"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17540171"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18626576"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19088076"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19150425"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20434986"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20501937"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20961246"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21765415"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23091055"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26334375"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8777433"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9244310"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9252186"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346484"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9520446"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9751059"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9813230"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<sequence length="745" mass="84640" checksum="4EA55C6FFC66FA16" modified="2011-01-11" version="2">
MERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCH
EIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQ
ILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGSLCTS
FVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPK
CIFACEEMSGEVRFSSHLPQPNSLCSLVVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRC
FVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGI
SLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPI
IQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKL
EFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAE
IMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRV
LKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQ
SSARSLVGSSLEGAVTPQTSAWLPPTSAEHDHSLSCVVTPQDGETSAQMIEENLNCLGHL
STIIHEANEEQGNSMMNLDWSWLTE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>